Unknown NCT04519398

Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events

Sponsor: Grigore T. Popa University of Medicine and Pharmacy

Conditions ARDS Corona Virus Infection Covid19 RAAS Thrombophilia Thromboses, Deep Vein Thromboses, Intracranial Thrombosis

Interventions Complete thrombophilic profile testing by multiplex PCR

Updated 8 times since 2020 Last updated: Aug 18, 2020 Started: Aug 18, 2020 Primary completion: Feb 17, 2021 Completion: Aug 18, 2021

This observational or N/A phase trial investigates ARDS and Corona Virus Infection and is currently ongoing. Grigore T. Popa University of Medicine and Pharmacy leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Nov 2022 [monthly]

Recruiting

▶ Show 3 earlier versions

Jan 2021 — Dec 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Sep 2020 — Nov 2020 [monthly]

Recruiting

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Grigore T. Popa University of Medicine and Pharmacy

Data source: Grigore T. Popa University of Medicine and Pharmacy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Iași, Romania